Compare · RWLK vs STE
RWLK vs STE
Side-by-side comparison of ReWalk Robotics Ltd. (RWLK) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RWLK and STE operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE is the larger of the two at $23.05B, about 332.5x RWLK ($69.3M).
- STE has hit the wire 16 times in the past 4 weeks while RWLK has been quiet.
- STE has more recent analyst coverage (17 ratings vs 0 for RWLK).
- Company
- ReWalk Robotics Ltd.
- STERIS plc (Ireland)
- Price
- -
- -
- Market cap
- $69.3M
- $23.05B
- 1M return
- -
- +8.14%
- 1Y return
- -
- -4.93%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 0
- 16
- Recent ratings
- 0
- 17
ReWalk Robotics Ltd.
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes wearable robotic exoskeletons for individuals with mobility impairments or other medical conditions in Israel, the United States, Europe, the Asia-Pacific, Latin America, and Africa. It offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for used in the rehabilitation of individuals with lower limb disability due to stroke; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers, institutions, and individuals, as well as through distributors. The company was formerly known as Argo Medical Technologies Ltd. and changed its name to ReWalk Robotics Ltd. ReWalk Robotics Ltd. was founded in 2001 and is headquartered in Yokneam Ilit, Israel.
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest RWLK
- VA STAND Act introduced in the United States Senate
- Lifeward Announces Reverse Share Split
- ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
- Lifeward announces the Centers for Medicare & Medicaid Services ("CMS") is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
- Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
- Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
- ReWalk Robotics Ltd. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
- ReWalk Robotics Expands Direct Sales Coverage to Canada
- ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
Latest STE
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward
- SEC Form 4 filed by Director Boulud Pierre
- SEC Form 4 filed by Director Feldmann Cynthia L
- SEC Form 4 filed by Director Holland Christopher S
- SEC Form 4 filed by Director Alegria Esther M.
- SEC Form 144 filed by STERIS plc (Ireland)